Abstract
Secondary degeneration is a process encompassing damage adjacent to a primary injury, usually involving increased Ca(2+) influx into neurons and glia. Lomerizine dihydrochloride is a calcium channel blocker with relatively selective CNS effects, currently in clinical trials for glaucoma. We have recently demonstrated that, following partial transection of the optic nerve (ON), 1 month of lomerizine treatment protects retinal ganglion cells (RGCs), incompletely preserves visual function and also limits elements of secondary degeneration, including macrophage infiltration. However, under some circumstances macrophages have been shown to have different supportive effects on RGC protection and regeneration, casting doubt on the benefit of longer term therapies that reduce macrophage numbers. Here, we determined whether shorter treatment times (1 day or 1 week) result in improved effects on RGC survival and visual function, and whether benefits are maintained after cessation of treatment. We demonstrate that 1 month of lomerizine is the minimum period required to restore the fast reset phase of the optokinetic nystagmus and maintain it for a further 2 months after cessation of treatment (p>0.05, not different from normal). While 1 w...Continue Reading
References
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·V L DawsonS H Snyder
May 1, 1996·The British Journal of Ophthalmology·H A Quigley
Jan 1, 1997·Nature Medicine·M J CroweM S Beattie
Sep 23, 1998·Experimental Neurology·E Yoles, M Schwartz
Nov 24, 1999·Clinical and Experimental Pharmacology & Physiology·H HaraM Hashimoto
Jul 6, 2000·The Journal of Comparative Neurology·R E BlancoJ M Blagburn
Sep 7, 2000·Brain Research Bulletin·J M Delgado-García
Nov 4, 2000·Journal of Neurotrauma·S H GrahamR S Clark
Mar 5, 2003·Journal of Neurotrauma·Qi CuiAlan R Harvey
Jul 29, 2003·Investigative Ophthalmology & Visual Science·Hana Levkovitch-VerbinDanielle F Valenta
Mar 24, 2004·Brain Research Bulletin·Michal Schwartz
Aug 4, 2004·Progress in Biophysics and Molecular Biology·Boris Khodorov
Feb 23, 2005·Current Drug Targets. CNS and Neurological Disorders·John J Shacka, Kevin A Roth
Feb 25, 2005·Investigative Ophthalmology & Visual Science·Michael BlairHarry Quigley
Mar 4, 2005·Vision Research·Jellali AbdeljalilPicaud Serge
Oct 15, 2005·Nature Reviews. Neuroscience·Michael Coleman
Dec 24, 2005·The Journal of Comparative Neurology·Kristina A KigerlPhillip G Popovich
Jan 18, 2006·Brain Research·Hideyuki YamadaMakoto Araie
Mar 15, 2006·Current Eye Research·Zahidul KarimTakazumi Taniguchi
Sep 12, 2006·Progress in Retinal and Eye Research·Gülgün Tezel
Sep 12, 2006·Progress in Retinal and Eye Research·Alan R HarveyQi Cui
Apr 6, 2007·Neuroscience·Q CuiA R Harvey
Dec 7, 2007·The European Journal of Neuroscience·Jian-Min LuoQi Cui
Apr 10, 2008·Ecotoxicology and Environmental Safety·Manuela HogieAnnie Reber
May 1, 2008·PloS One·Hugh Cahill, Jeremy Nathans
Oct 22, 2008·Nature Reviews. Neuroscience·Robin J M Franklin, Charles Ffrench-Constant
Jan 3, 2009·Experimental Neurology·Melinda FitzgeraldSarah A Dunlop
Mar 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·John C GenselPhillip G Popovich
May 29, 2009·Investigative Ophthalmology & Visual Science·Melinda FitzgeraldSarah A Dunlop
Oct 27, 2009·Journal of Neurotrauma·Melinda FitzgeraldSarah A Dunlop
Citations
Aug 21, 2013·Neuropharmacology·Donna L SavigniMelinda Fitzgerald
Sep 9, 2010·Journal of Neurotrauma·Melinda FitzgeraldSarah A Dunlop
Mar 9, 2011·Journal of Neurotrauma·Sophie C PayneMelinda Fitzgerald
Dec 18, 2013·PloS One·Patrick H W ChuHenry H L Chan
Sep 11, 2014·Neural Regeneration Research·Melinda Fitzgerald
Jul 7, 2015·Experimental Eye Research·Stephanie L Grillo, Peter Koulen
Mar 14, 2012·Small·James HarrisonMelinda Fitzgerald
Oct 16, 2015·Assay and Drug Development Technologies·Susanne DienerBettina Lorenz-Depiereux
Apr 15, 2011·International Journal of Molecular Imaging·Joe AoyagiYasuo Iwasaki
Dec 8, 2017·Frontiers in Neuroscience·Leanne T Y CheungKin Chiu
Jul 13, 2019·Developmental Neurobiology·George G BastakisMaria Savvaki
Apr 13, 2017·Neural Regeneration Research·Nathanael J YatesMelinda Fitzgerald
Feb 7, 2020·Journal of Neurotrauma·Andrew WarnockMelinda Fitzgerald
Jul 16, 2020·Clinical Neuropharmacology·Akiko Watanabe-HosomiToshiki Mizuno
Sep 19, 2020·Clinical Neuropharmacology·Akiko Watanabe-HosomiToshiki Mizuno
Mar 6, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Narjes ShahsavaniSoheila Karimi-Abdolrezaee
Oct 29, 2020·ACS Omega·Takuma SatoYoichi M A Yamada
Oct 16, 2010·Current Opinion in Ophthalmology